Encompass Health reports Q3 adjusted EPS 86c, consensus 77c

Reports Q3 revenue $1.21B, consensus $1.19B. “We are very pleased with our third quarter performance,” said President and CEO of Encompass Health Mark Tarr. “Revenue growth of 10.8% driven primarily by strong discharge growth combined with year-over-year improvement in labor costs resulting in Adjusted EBITDA growth of 21.6%. Our value proposition and operating strategy continue to be validated and we remain highly optimistic about the long-term prospects of our business. We are updating our 2023 guidance to reflect our third quarter results and expectations for the balance of the year.”